Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Suntory researchers discover new treatments for convulsions, ischemia

April 23, 1998

AIT-082 enhances memory function in preclinical model

April 23, 1998

Sepracor receives U.S. patent protection for single-isomer SSRI

April 22, 1998

Unfavorable phase III results lead to setback in CerAxon development

April 22, 1998

Orphan drug designation granted for Xerecept

April 21, 1998

Heterocyclic tachykinin antagonists from Sanofi

April 21, 1998

Dainippon presents a BZP inverse agonist for the treatment of dementia

April 21, 1998

MS&D discovers agents for safely enhancing cognition

April 21, 1998

New data reported for donepezil hydrochloride

April 21, 1998

Collaborations formed to further development of memantine

April 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...